OnysilinCAS# 73695-94-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 73695-94-0 | SDF | Download SDF |
PubChem ID | 12041831 | Appearance | Cryst. |
Formula | C17H16O5 | M.Wt | 300.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S)-5-hydroxy-6,7-dimethoxy-2-phenyl-2,3-dihydrochromen-4-one | ||
SMILES | COC1=C(C(=C2C(=O)CC(OC2=C1)C3=CC=CC=C3)O)OC | ||
Standard InChIKey | FAUVORGACLCWKX-LBPRGKRZSA-N | ||
Standard InChI | InChI=1S/C17H16O5/c1-20-14-9-13-15(16(19)17(14)21-2)11(18)8-12(22-13)10-6-4-3-5-7-10/h3-7,9,12,19H,8H2,1-2H3/t12-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Onysilin has anti-atherosclerotic activity. |
Onysilin Dilution Calculator
Onysilin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.33 mL | 16.65 mL | 33.3 mL | 66.6001 mL | 83.2501 mL |
5 mM | 0.666 mL | 3.33 mL | 6.66 mL | 13.32 mL | 16.65 mL |
10 mM | 0.333 mL | 1.665 mL | 3.33 mL | 6.66 mL | 8.325 mL |
50 mM | 0.0666 mL | 0.333 mL | 0.666 mL | 1.332 mL | 1.665 mL |
100 mM | 0.0333 mL | 0.1665 mL | 0.333 mL | 0.666 mL | 0.8325 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Naringenin 5-rhamnoside
Catalog No.:BCN2747
CAS No.:
- HEPES
Catalog No.:BCC7590
CAS No.:7365-45-9
- H-Asp-OBzl
Catalog No.:BCC2882
CAS No.:7362-93-8
- p-Coumaric acid ethyl ester
Catalog No.:BCN4289
CAS No.:7362-39-2
- 5-Amino-1-(2-hydroxyethyl)pyrazole
Catalog No.:BCC8727
CAS No.:73616-27-0
- 1-(4-Methoxycinnamoyl)pyrrole
Catalog No.:BCN4027
CAS No.:736140-70-8
- Xylazine
Catalog No.:BCC5167
CAS No.:7361-61-7
- 3-Hydroxybenzylamine
Catalog No.:BCN1804
CAS No.:73604-31-6
- (-)-Bicuculline methobromide
Catalog No.:BCC6555
CAS No.:73604-30-5
- Omeprazole
Catalog No.:BCC1254
CAS No.:73590-58-6
- 27-p-Coumaroyloxyursolic acid
Catalog No.:BCN4288
CAS No.:73584-67-5
- Mevastatin
Catalog No.:BCN2568
CAS No.:73573-88-3
- Oxypeucedanin
Catalog No.:BCN2494
CAS No.:737-52-0
- Acetylursolic acid
Catalog No.:BCN4290
CAS No.:7372-30-7
- Fmoc-Ser-OH
Catalog No.:BCC3541
CAS No.:73724-45-5
- Fmoc-Thr-OH
Catalog No.:BCC3549
CAS No.:73731-37-0
- Broussonin B
Catalog No.:BCN4593
CAS No.:73731-86-9
- Broussonin A
Catalog No.:BCN4592
CAS No.:73731-87-0
- Acanthoside B
Catalog No.:BCN4291
CAS No.:7374-79-0
- N-(4-Aminobenzoyl)-β-alanine
Catalog No.:BCC9056
CAS No.:7377-08-4
- 360A iodide
Catalog No.:BCC1308
CAS No.:737763-37-0
- Kihadanin B
Catalog No.:BCN3441
CAS No.:73793-68-7
- Trimethoprim
Catalog No.:BCC4873
CAS No.:738-70-5
- Bergamotine
Catalog No.:BCN2733
CAS No.:7380-40-7
Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.[Pubmed:25442273]
Phytomedicine. 2014 Oct 15;21(12):1651-7.
INTRODUCTION: Resistance of cancer to chemotherapy is a main cause in treatment failure. Naturally occurring chalcones possess a wide range of biological activities including anti-cancer effects. In this work, we evaluated the antiproliferative activity of three chalcones [4'-hydroxy-2',6'-dimethoxychalcone (1), cardamomin (2), 2',4'-dihydroxy-3',6'-dimethoxychalcone (3)], and four flavanones [(S)-(-)-pinostrobin (4), (S)-(-)-Onysilin (5) and alpinetin (6)] toward nine cancer cell lines amongst which were multidrug resistant (MDR) types. METHODS: The resazurin reduction assay was used to detect the antiproliferative activity of the studied samples whilst flow cytometry for the mechanistic studies of the most active molecule (1). RESULTS: IC50 values in a range of 2.54 muM against CEM/ADR5000 leukemia cells to 58.63 muM toward hepatocarcinoma HepG2 cells were obtained with 1. The lowest IC50 values of 8.59 muM for 2 and 10.67 muM for 3 were found against CCRF-CEM cells leukemia cells, whilst the corresponding values were above 80 muM for 4 and 6. P-glycoprotein-expressing and multidrug-resistant CEM/ADR5000 cells were much more sensitive toward compound 1 than toward doxorubicin and low cross-resistance or even collateral sensitivity was observed in other drug-resistent cell lines to this compound. Normal liver AML12 cells were more resistant to the studied compounds than HepG2 liver cancer cells, indicating tumor specificity at least to some extent. Compound 1 arrested the cell cycle between Go/G1 phase, strongly induced apoptosis via disrupted mitochondrial membrane potential (MMP) and increased production of reactive oxygen species (ROS) in the studied leukemia cell line. CONCLUSIONS: Chalcone 1 was the best tested cytotoxic molecule and further studies will be performed in order to envisage its possible use in the fight against multifactorial resistant cancer cells.
Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).[Pubmed:20465823]
Chin Med. 2010 May 13;5:17.
Andrographis paniculata (Burm. f.) Nees (Acanthaceae) is a medicinal plant used in many countries. Its major constituents are diterpenoids, flavonoids and polyphenols. Among the single compounds extracted from A. paniculata, andrographolide is the major one in terms of bioactive properties and abundance. Among the andrographolide analogues, 14-deoxy-11,12-didehydroandrographolide is immunostimulatory, anti-infective and anti-atherosclerotic; neoandrographolide is anti-inflammatory, anti-infective and anti-hepatotoxic; 14-deoxyandrographolide is immunomodulatory and anti-atherosclerotic. Among the less abundant compounds from A. paniculata, andrograpanin is both anti-inflammatory and anti-infective; 14-deoxy-14,15-dehydroandrographolide is anti-inflammatory; isoandrographolide, 3,19-isopropylideneandrographolide and 14-acetylandrographolide are tumor suppressive; arabinogalactan proteins are anti-hepatotoxic. The four flavonoids from A. paniculata, namely 7-O-methylwogonin, apigenin, Onysilin and 3,4-dicaffeoylquinic acid are anti-atherosclerotic.